Australian Patent Application

Imidazoquinolines as dual lipid kinase and mTOR inhibitors

Source-linked patent metadata for Imidazoquinolines as dual lipid kinase and mTOR inhibitors, including priority, record stage and longevity-topic connections.

Australian application snapshot

Patent application record

This privacy-minimal view describes one official Australian patent application record. It is not presented as a complete worldwide patent family.

Application number
AU2011250672
Earliest priority
February 20, 2007
Application date
November 9, 2011
Source record
1
Patent offices
1
Patent-to-Evidence Translation Map

What is happening in the same scientific field?

These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.

Organizations

Why names are absent

This feed intentionally excludes party names and contact details to minimise personal data. Open the official record when a name is consequential.

Longevity context

Topics connected by metadata

Rapamycin82% metadata match
Technical classification

How the patent office classifies this invention

A61K31/4745 · A61P11/00 · A61P25/00 · A61P27/02 · A61P31/04 · A61P31/12 · A61P35/00 · A61P37/00 · A61P43/00 · A61P7/00 · A61P9/00

Verify in the original patent source →